AR225153A1 - Un procedimiento para la preparacion de sulfato de vindesina - Google Patents

Un procedimiento para la preparacion de sulfato de vindesina

Info

Publication number
AR225153A1
AR225153A1 AR278306A AR27830679A AR225153A1 AR 225153 A1 AR225153 A1 AR 225153A1 AR 278306 A AR278306 A AR 278306A AR 27830679 A AR27830679 A AR 27830679A AR 225153 A1 AR225153 A1 AR 225153A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
vindesine sulphate
vindesine
sulphate
Prior art date
Application number
AR278306A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AR225153A1 publication Critical patent/AR225153A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AR278306A 1978-10-10 1979-10-02 Un procedimiento para la preparacion de sulfato de vindesina AR225153A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94959578A 1978-10-10 1978-10-10

Publications (1)

Publication Number Publication Date
AR225153A1 true AR225153A1 (es) 1982-02-26

Family

ID=25489302

Family Applications (1)

Application Number Title Priority Date Filing Date
AR278306A AR225153A1 (es) 1978-10-10 1979-10-02 Un procedimiento para la preparacion de sulfato de vindesina

Country Status (32)

Country Link
EP (1) EP0009996B1 (pt)
JP (1) JPS5553295A (pt)
KR (1) KR850000150B1 (pt)
AR (1) AR225153A1 (pt)
AT (1) AT370422B (pt)
AU (1) AU525702B2 (pt)
BE (1) BE879213A (pt)
BG (1) BG34763A3 (pt)
CA (1) CA1114817A (pt)
CH (2) CH645120A5 (pt)
CS (1) CS235503B2 (pt)
DD (1) DD146461A5 (pt)
DE (1) DE2964913D1 (pt)
DK (1) DK146823C (pt)
EG (1) EG14140A (pt)
ES (1) ES484827A1 (pt)
FI (1) FI70223C (pt)
FR (1) FR2438659A1 (pt)
GB (1) GB2031893B (pt)
GR (1) GR72394B (pt)
HU (1) HU180744B (pt)
IE (1) IE48958B1 (pt)
IL (1) IL58390A (pt)
LU (1) LU81763A1 (pt)
MY (1) MY8500569A (pt)
NZ (1) NZ191744A (pt)
PH (1) PH16092A (pt)
PL (1) PL117678B1 (pt)
PT (1) PT70269A (pt)
RO (1) RO77380A (pt)
YU (1) YU241179A (pt)
ZA (1) ZA795268B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4558053A (en) * 1983-12-21 1985-12-10 Eli Lilly And Company Naphthalene-1,5-disulfonate salts of dimeric indole-dihydroindole alkaloids
CN112592357B (zh) * 2020-12-22 2022-03-22 海南长春花药业有限公司 一种硫酸长春地辛的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
GR69783B (pt) * 1976-09-08 1982-07-07 Lilly Co Eli

Also Published As

Publication number Publication date
KR850000150B1 (ko) 1985-02-28
MY8500569A (en) 1985-12-31
FR2438659A1 (fr) 1980-05-09
DE2964913D1 (en) 1983-03-31
IE48958B1 (en) 1985-06-26
FI70223C (fi) 1986-09-15
FI70223B (fi) 1986-02-28
IE791914L (en) 1980-04-10
PH16092A (en) 1983-06-20
IL58390A (en) 1982-07-30
CH645120A5 (fr) 1984-09-14
LU81763A1 (fr) 1980-01-24
JPS628119B2 (pt) 1987-02-20
FI793065A (fi) 1980-04-11
DD146461A5 (de) 1981-02-11
YU241179A (en) 1983-01-21
CA1114817A (en) 1981-12-22
AU525702B2 (en) 1982-11-25
NZ191744A (en) 1981-05-29
PL117678B1 (en) 1981-08-31
PT70269A (de) 1979-11-01
ES484827A1 (es) 1980-10-01
BE879213A (fr) 1980-04-08
DK422979A (da) 1980-04-11
AT370422B (de) 1983-03-25
GB2031893B (en) 1983-03-30
KR830001282A (ko) 1983-04-30
BG34763A3 (en) 1983-11-15
CS235503B2 (en) 1985-05-15
GB2031893A (en) 1980-04-30
AU5142779A (en) 1980-04-17
EP0009996B1 (en) 1983-02-23
HU180744B (en) 1983-04-29
ZA795268B (en) 1981-05-27
GR72394B (pt) 1983-11-01
CH649301A5 (fr) 1985-05-15
EP0009996A1 (en) 1980-04-16
JPS5553295A (en) 1980-04-18
IL58390A0 (en) 1980-01-31
FR2438659B1 (pt) 1983-03-18
DK146823B (da) 1984-01-16
RO77380A (ro) 1981-11-04
PL218756A1 (pt) 1980-06-16
ATA658279A (de) 1982-08-15
DK146823C (da) 1984-07-02
EG14140A (en) 1983-09-30

Similar Documents

Publication Publication Date Title
ES494300A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos
ES484097A0 (es) Un procedimiento para la preparacion de nuevos derivados de-4-anilinoquinazolinas
ES490215A0 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
ES487358A0 (es) Un procedimiento para la preparacion de compuestos de cefem y cefam
ES489751A0 (es) Un procedimiento para la preparacion de monacolina k
ES488678A0 (es) Un procedimiento para la preparacion de nuevos derivados he-terociclicos
ES485620A0 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
ES490213A0 (es) Un procedimiento para la preparacion de fenetanolaminas
ES487380A0 (es) Un procedimiento para la preparacion de supositorios estables
ES489470A0 (es) Un procedimiento para la preparacion de 9-aminoalquilfluore-no
ES488210A0 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina
ES484930A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES486022A0 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporina
ES493543A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hexadieno
ES489048A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
AR225153A1 (es) Un procedimiento para la preparacion de sulfato de vindesina
MX4867E (es) Procedimiento para la preparacion de ester de sulfato de colecistoquinin-pancreozimin octapeptidamida
ES493200A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES485214A0 (es) Un procedimiento para la fabricacion de un stick de nockey.
ES490617A0 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
ES489646A0 (es) Un procedimiento para la preparacion de derivados de cefa- losporina
ES487087A0 (es) Un procedimiento para la preparacion de n-cloroimidas
ES486666A0 (es) Un procedimiento para la preparacion de carbetoxi-carbonila-mino-pirimidinas
MX5587E (es) Un procedimiento para la preparacion de 2-cloro-4-etilamino-6-isopropilamino-s-triazina
ES489540A0 (es) Un procedimiento para la preparacion de 4-hidroximetil-5-me-tilimidazol